Student Presentations, Defenses, and Activities
Pharm.D. Seminars (Advised or Co-Advised)
|
DATE |
STUDENT |
PHARM.D. SEMINAR TITLE |
|
March 30, 2007 |
Lily Huang |
Acupoint Stimulations in the Treatment of Postoperative Nausea and Vomiting |
|
March 30, 2007 |
Brian Stahl |
Darunivar: a New Protease Inhibitor for the Management of Antiretroviral Experienced Patients |
|
March 28, 2007 |
Kristy Dudash |
Myozyme for the Treatment of Infantile Pompe Disease |
|
March 28, 2007 |
Gordon Pokorny |
The Role of Abatacept in the Treatment of Rheumatoid Arthritis |
|
March 31, 2006 |
Svetlana Koroteyeva |
The Use of Megace for the Management of Significant Weight Loss in Elderly
|
|
March 31, 2006 |
Kaher Asad |
Strontium Ranelate: A New Treatment for Postmenopausal Osteoporosis |
|
March 31, 2006 |
Brenda Strang |
Baclofen and the Treatment of Gastroesophageal Reflux Disease
|
|
March 28, 2006 |
Lap Pan Chu |
Acupuncture and Its Role in the Management of Osteoarthritis |
|
March 28, 2006 |
Tara Woofter |
Melatonin Agonists as Sleep Aids |
|
March 28, 2006 |
Bonnie Gedeon |
Rasagiline: A New MAO-B Inhibitor for the Treatment of Parkinson’s Disease
|
|
March 27, 2006 |
You-John Chow |
Using Enfuvirtide (Fuzeon) for the Treatment of HIV Infection |
|
April 15, 2005 |
Brittany Langel |
The Importance of Imaging in the Diagnosis of Appendicitis |
|
March 22, 2002 |
Frank Rigelski |
The Use of HMG-CoA Inhibitors in the Reduction of C-Reactive Protein Levels in the Prevention of Coronary Events (Measuring High-Sensitivity CRP Levels to Assess Cardiovascular Risk) |
|
March 22, 2002 |
Igdaliah Jackson |
Efficacy of Combination Therapy in the Treatment of Uncomplicated Plasmodium falciparum Malaria |
|
March 30, 2001 |
David Chen |
Determination of Fluoroquinolone Resistance in the Opportunistic Bacteria
Alcaligenes xylosoxidans subspecies xylosoxidans. |
Completed Thesis Defenses (Committees Served Upon)
|
STUDENT |
DEGREE |
DATE |
DEGREE TYPE |
THESIS ADVISOR |
THESIS TITLE | ||||
|
Richard W. Dudley |
Ph.D. |
December 2006 |
Medicinal Chemistry |
Steven M. Peseckis, Ph.D. |
Design, Synthesis and Evaluation of Cellular Entry and Localization of Fluorescent, Varied Lipophilicity Molecules | ||||
|
Rahul S. Khupse |
Ph.D. |
December 2006 |
Medicinal Chemistry |
Paul W. Erhardt, PhD |
Total Synthesis of the Glyceollins I, II and Elaboration of Several Intermediates Having Potential Pharmacological Activities | ||||
|
Marc C. Christensen |
Ph.D. |
April 2006 |
Medicinal Chemistry |
Steven M. Peseckis, Ph.D. |
Molecular Modeling of Wild Type and Mutant Human M1 Muscarinic Acetylcholine Receptors with Ligands in a Lipid Bilayer | ||||
|
Brian Dougan |
M.S. |
April 2006 |
Pharmacology |
Ezdihar Hassoun, Ph.D. |
Induction of Oxidative Stress by Di- and Trichloroacetates and Mixtures of the Compounds in Mice | ||||
|
Jinal Desai |
M.S. |
June 2005 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Development of Controlled Released Formulations of Dimenhydrinate Using Ethyl Cellulose: Application of the Solid Dispersion and Wet Granulation Technique | ||||
|
Amanda Jones |
M.S. |
May 2005 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Pharmaceutical Eutectics: Formation, Evaluation and Relevance in Preformulation Studies Using Thermal Analytical Techniques | ||||
|
Indranil Rao |
M.S. |
May 2005 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Effect of Antioxidants on the Oxidative Stability of Vegetable Oils and the Construction of Vapor Pressure Curves for Vegetable Oils and Their Key Components by Thermal Analytical Techniques | ||||
|
Pinaki Basu |
M.S. |
May 2005 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Crystallization Kinetics of Amorphous Ketoconazole | ||||
|
Ruel C. Nacario |
Ph.D. |
May 2005 |
Chemistry |
Richard A. Hudson, Ph.D. |
Reductive Monoalkylation of Primary Amines with Nitriles: A Mild Synthesis of Secondary Amines and Design and Partial Synthesis of a Constrained Geometry Serine Protese Model Catalyst | ||||
|
Bin Tang |
Ph.D. |
May 2004 |
Medicinal Chemistry |
William S. Messer, Jr., Ph.D. |
The Effect of the M1-Selective Muscarinic Agonist CDD-0102 and Presenilin 1 Mutations on Amyloid Precursor Protein Processing and Cell Survival | ||||
|
Marcia Williams |
M.S. |
May 2004 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
A Comparison of the Disintegration Properties of Three Starches and a Superdisintegrant - A Novel Approach | ||||
|
Bhaswati DattaChowdhury |
M.S. |
May 2004 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Application of Theoretical Models in the Crystallization Kinetics of Pharmaceuticals from the Amorphous State | ||||
|
Lalit M. Oberoi |
M.S. |
May 2004 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Formulation of a fast-acting ibuprofen suspension by using nicotinamide as hydrotropic agent - application of DSC, spectroscopy and microscopy in assessment of the type of interaction | ||||
|
Sunghan Yim |
Ph.D. |
December 2003 |
Medicinal Chemistry |
Katherine A. Wall, Ph.D. |
Role of IL-12 and Interferon-gamma in Active and Passive Experimental Autoimmune Myasthenia Gravis | ||||
|
Mohammad K. Mohammad |
Ph.D. |
December 2003 |
Medicinal Chemistry |
Marcia F. McInerney, Ph.D. |
The Role of Innate Immunity in Type I Diabetes | ||||
|
Sandipan Sinha |
M.S. |
May 2003 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Preparation and Evaluation of the Amorphous Form of Sulfapyridine - The Effect of Relative Humidity, Excipients and Temperature | ||||
|
Pradyot Nandi |
M.S. |
May 2003 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Thermal Characterization and Kinetics of Essential Oils and Their Major Constituents Used in Aromatherapy | ||||
|
Rajesh Vadlapatla |
M.S. |
May 2003 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Solid State Characterization of Anhydrous and Hydrous Forms of Aminophylline and Their in-vitro Drug Release Pattern | ||||
|
Rahim Lila |
Ph.D. |
December 2002 |
Medicinal Chemistry |
Steven M. Peseckis, Ph.D. |
|
A New Bioinformatic Resource: A Heterotrimeric G-Protein Database (hGPDB) | ||||
|
Trisha Lee Whipple |
M.S. |
December 2002 |
Pharmacology |
William S. Messer, Jr. Ph.D. |
|
In vivo characterization of tetra-(ethylene glycol)-(3-methoxy-1,2,5-thiadiazol-4-yl) [3-(1-methyl-1,2,5,6-tetrahydropyrid-3-yl)-1,2,5-thiadiazol-4-yl] ether hydrochloride | ||||
|
Doba Jackson |
Ph.D. |
July 2002 |
Chemistry |
Gloria Borgstahl. Ph.D. |
|
Analysis of the human Rad52/RPA complex: characterization of the interacting regions, DNA binding activity, and higher order complexes | ||||
|
Minjia Zhang |
M.S. |
July 2002 |
Medicinal Chemistry |
William S. Messer, Jr. Ph.D. |
|
Pharmacological Evaluation of Selective Muscarinic Acetylcholine Receptor Agonists | ||||
|
Nagarajan Thyagarajapuram |
M.S. |
June 2002 |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Analytical Method Development of Amiodarone Hydrochloride: Formulation and Stability Studies of Extemporaneous Suspension of Amiodarone Hydrochloride | ||||
|
Yang Cao |
Ph.D. |
January 2002 |
Medicinal Chemistry |
William S. Messer, Jr. Ph.D. |
|
Development of Novel Bivalent 1,2,5,6-Tetrahydropyridyl-1,2,5-Thiadiazole Derivatives as Selective, Potent, and Efficacious Human M1 Muscarinic Agonists for the Treatment of Alzheimer's Disease | ||||
|
Chunli Huang |
M.S. |
December 2001 |
Medicinal Chemistry |
Richard A. Hudson, Ph.D. |
Rational Design and Synthesis of Masked Quinone Methides as Potential Selective HIV-RT DNA-Strand-Transfer Inhibitors | ||||
|
Abeer H. El-Gharbawy |
Ph.D. |
December 2001 |
Medicinal Chemistry |
Channing Hinman, Ph.D. |
Cobra Cytotoxin-A Cascade of Events Leading To Cell Death | ||||
|
Xinyan Huang |
Ph.D. |
May 2002 (11/19/01) |
Biology |
Richard W. Komuniecki, Ph.D. |
Alternative-splicing of 5-HT2 receptors in the pharynx and body wall muscle of the parasitic nematode, Ascaris suum. | ||||
|
Ravi Shanker V. Vedula |
M.S. |
December 2001 (12/01) |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
A study of the Effect of Particle Size and Other Parameters on the Suspension Stability of Pumice | ||||
|
Jill A. Trendel |
Ph.D. |
November 2001 |
Biology |
Keith Johnson, Ph.D. |
Cadherin Induced Differential Gene Expression in Human Keratinocytes | ||||
|
Cindy Qian Zhu |
M.S. |
August 2001 (8/1/01) |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
|
A Hindered Settling Behavior Study for Calcium Hydrogen Phosphate Aqueous Suspensions - Particle Size Analysis and Their Associate Liquid Determined Using Thermal Analysis | ||||
|
Divya Menon |
M.S. |
August 2001 (7/20/01) |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
|
A Thermal Analysis Study of the Tabletting of Nicotinic Acid | ||||
|
Anasuya Hazra |
M.S. |
August 2001 (7/16/01) |
Pharmaceutics |
Kenneth S. Alexander, Ph.D. |
Characterization and Kinetics of Essential Oils and Their Key components Using Thermal Analytical Techniques | ||||
|
Fenghua Liu |
M.S. |
May 2001 |
Medicinal Chemistry |
William S. Messer, Jr. Ph.D. |
Pharmacological Characterization of Human M1 and M Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of Transmembrane Domain VI and the Third Extracellullar Loop | ||||
|
Charles A. Smith |
Ph.D. |
December 2000 (8/2000) |
Medicinal Chemistry |
Channing Hinman Ph.D. |
The Importance of Cardiotoxin Atra III Synthetic Peptide Loop 1 Amino Acid Residues Asparagine 4 & Tyrosine 11 in Relation to Anti-Cancer Activity and Binding to Leukemic T-Cell Surface Receptor | ||||
|
Abel Henry Saturne Jr. |
M.S. |
July 2000 |
Pharmacology |
Kenneth A. Bachman, Ph.D. |
In Vitro Analysis of Liver Metabolism of Vitamin D3: Using Midazolam as Probe | ||||
|
Nimish Meta |
Ph.D. |
May 2000 |
Medicinal Chemistry |
James T. Slama, Ph.D. |
|
Synthesis of chiral carboxylic pentofuranosylamine analogs - versatile precursors for novel carboxylic nucleosides | ||||
|
Wellington Nguyen Pham |
Ph.D. |
May 2000 |
Medicinal Chemistry |
Steven M.Peseckis, Ph.D. |
Design, Syntheses, and Biological Evaluation of Dual Fatty Acylated Peptide Mimetics of Gi(alpha) N-Termini | ||||
|
Vyjayanthi Krishnan |
Ph.D. |
May 2000 |
Medicinal Chemistry |
Steven M.Peseckis, Ph.D. |
First Lipophilically Modified Peptide Analogs of Gi(alpha) N-terminus that Affect Muscarinic Receptor Ligand Binding | ||||
|
Deanna Brickley |
M.S. |
August 1999 |
Medicinal Chemistry |
Marcia F. McInerney., Ph.D. |
|
Development of a Monoclonal Antibody to the Mouse Insulin Receptor | ||||
|
Hong Huang |
M.S. |
May 1999 |
Pharmacology |
Kenneth A. Bachmann, Ph.D. |
An in vitro study of 25-hydroxylation of vitamin D3 by human cytochrome P450 enzymes | ||||
|
Sandeep N. Athalye |
M.S. |
May 1999 (3/15/1999) |
Pharmacology |
Gerald Sherman, Ph.D. |
Development of a Computer-Based Clinical Decision Support System for the Pharmacotherapy of Hypertension | ||||
|
Xi-Ping Huang |
Ph.D. |
May 1999 |
Medicinal Chemistry |
William S. Messer, Jr. Ph.D. |
Site-Directed Mutagenesis and Pharmacological Studies of Human M1 Muscarinic Acetylcholine Receptors | ||||
|
Sheela Sitaraman |
Ph.D. |
April 1998 |
Medicinal Chemistry |
Katherine A. Wall. Ph.D. |
Myasthenia Gravis - Role of Cytokines in Disease and Design of Therapy | ||||
|
Hao Zhang |
M.S. |
December 1997 |
Medicinal Chemistry |
William S. Messer Jr., Ph.D. |
Syntheses and Muscarinic Activities of Sulfur Analogues of Tetrahydropyrimidine Derivatives | ||||
|
Jamie Nguyen |
M.S. |
December 1995 |
Medicinal Chemistry |
Marcia F. McInerney., Ph.D. |
Investigations in Type I Diabetes: Inhibitors of Cytokine-mediated b Cell Destruction and Identification of Synaptophysin as an Autoantigen | ||||
|
Liping Guan |
M.S. |
April 1995 |
Medicinal Chemistry |
Marcia F. McInerney., Ph.D. |
Characterization of an Islet Specific CD8+ Hybrid Cell Clone 4A7.715 | ||||
|
Matthew J. Seidel |
M.S. |
April 1995 |
Medicinal Chemistry |
Marcia F. McInerney., Ph.D. |
Bioassay Development to Explore Cytokine-Induced Beta-Cell Dysfunction As A Model of Type I Diabetes | ||||